This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Nokia announced today that it has signed a deal with Amazon to end all patentlitigation between the two companies, the terms of which are confidential.
In litigation news. For the third consecutive month, Tesla finds itself involved in a new patentinfringement lawsuit, this latest time as a defendant in an action filed by Graphite Charging Company LLC on August 4, 2023 in the Western District of Texas. By: Mintz - Energy & Sustainability Viewpoints
International Trade Commission (ITC) remain an efficient and powerful method for American businesses seeking relief from foreign acts of unfair competition, including infringement of intellectual property rights. In 2024, the number of complaints filed at the ITC rebounded after the low in 2023.
2023 WL 6381821, No. 28, 2023) Cap Export alleged that Zinus fraudulently obtained a patent after Zinus used the public domain bed-in-a-box sets of a non-party as the basis for its patent application. The underlying patentlitigation allegedly fraudulently induced Cap Export to enter into a $1.1 Zinus, Inc.,
Stroud is General Counsel at Unified Patents – an organization often adverse to litigation-funded entities. [1] Patent assertion finance today is a multibillion-dollar business. [2] 2] Virtually nonexistent in the patent space in the U.S. Patent assertion finance today is a multibillion-dollar business. [2]
by Dennis Crouch Rule 1 of the Federal Rules of Civil Procedure sets out a bold goal for civil litigation: “ the just, speedy, and inexpensive determination of every action.” ” Patentlitigation is rarely speedy; quite expensive; and, many would argue, often unjust. Lite-Netics LLC v. 4th — (Fed.
Adding another leaf to the FCM patentlitigation saga, the Delhi High Court on September 19 refused to grant an interim injunction to Vifor considering the launch of the Biological E’s product in the market. Macleods Pharmaceuticals Ltd , the order dated April 11, 2023, in the case of Vifor (International) Ltd.
This case pertains to patentinfringement concerning two process patents related to the fungicide Azoxystrobin. Indian IP litigation has of late admitted new forms of engagement of concurrent evidence such as the hot-tubbing and the confidentiality club (previously discussed here & here ). It noted that Serial No.
2023) , the Federal Circuit once again granted a writ of mandamus , ordering a patentinfringement case to be transferred out of Judge Albright’s courtroom in the Western District of Texas (WDTX). states, including Texas, is no stranger to litigation in the Lone Star state.
On June 1, 2021, the Fourth Amendment to the Chinese Patent Law became effective. An important part of the amendment is the introduction by Article 76 of the patent linkage system in China – a system for litigation of drug patents prior to market entry of generics, similar to that provided by the Hatch Waxman Act in the US.
Mo 2023) Bayer and its subsidiary Monsanto have filed a new set of patentinfringement lawsuits against farmers who saved seeds and replanted them in violation of Monsanto Roundup Ready patents and license agreements. Monsanto’s original patents on genetically modified plants have all expired. Pierce, et al.
The Commission’s injunctive powers provide an attractive forum for Complainants seeking relief from patentinfringementlitigation and other unfair acts. In 2023, the number of complaints filed in federal courts was down over previous years, and the ITC was no exception.
In June 2023, as is widely known, more than 50 years of efforts to create a pan-European patent jurisdiction were finally successful and the Unified Patent Court opened its doors.
While a ruling is not expected for another month or so, several signs point to the Court of Appeal adjusting the May 2023 ruling by Mr Justice Marcus Smith at the High Court of England and Wales in a way that increases the damages for patentinfringement that are ultimately awarded to Optis.
This high-profile case revolves around allegations of patentinfringement concerning two patents (“Suit Patents”), both relating to ‘Pertuzumab,’ a monoclonal antibody (Mab) biologic used in inhibiting tumor growth. and Ors (2023, Petition Withdrawn) Justice Pratibha M. Find it here.
Microsoft on Monday February 6, 2023, and the CAFC issued its opinion in the case this past Thursday. citizen, sued Xiaomi, a Chinese multinational corporation, for patentinfringement in New York. Court of Appeals for the Federal Circuit (CAFC) in Maalouf v. This case has curious origins.
One of the characteristics of patentinfringementlitigation in the aftermath of the Supreme Court's decision in Markman v. Westview Instruments, Inc. holding that claim construction was a matter of law to be reviewed de novo by the Federal Circuit; but see Teva Pharma. Sandoz, Inc.)
The Patent Office instituted reexamination of all asserted claims of the patent a few weeks after the court’s claim construction hearing and ruling in January 2022. The case is set for trial to begin in May 2023. Trial is set for January 2023. Onpoint Sys., Protect Animals With Satellites, LLC , No.
By Jason Rantanen It’s time for the January 2023 Federal Circuit statistics update! Given what happened in appeals this year, I’d expect an increase in Federal Circuit decisions in 2023, recognizing that it takes about 13 months on average from filing to decision. Edward Elgar forthcoming) (preprint available at [link] ).
The Commission’s injunctive powers provide an attractive forum for Complainants seeking relief from patentinfringementlitigation and other unfair acts. In 2023, the number of complaints filed in federal courts was down over previous years, and the ITC was no exception.
This is the latest in the series titled “NPE Showcase,” where we discuss high-volume non-practicing entities (or as some call them, “patent trolls”). This installment will focus on NPE litigation as a whole, and what to expect in 2023. So where do things stand in 2023? Business was booming.
alleging that Pfizer’s respiratory syncytial virus (“RSV”) vaccine ABRYSVO infringes four U.S. patents covering GSK’s rival RSV vaccine, AVREXY. Food and Drug administration in May 2023 for use in adults over age 60, becoming the world’s first approved RSV immunizations for adults. Patent Nos.
Clever covert spy activities during active litigation may backfire. DeSoto recommended dismissing all of Site 2020’s patentinfringement claims against Superior Traffic with prejudice because Site 2020 acted in bad faith and “engaged deliberately in deceptive practices that undermine the integrity of judicial proceedings.”.
Although a patent can be challenged in federal district court, an IPR is an expedited and less costly procedure than federal court litigation. Thus, an IPR is a useful method for a defendant in a patentlitigation lawsuit to invalidate the patent in issue. In Apple v.
Vidal (No 23-135): This case challenges the “ Fintiv rule” that restricts the initiation of inter partes review in cases where parallel district court litigation is pending. Here, in a first case against Huawei, the Magistrate had recommended a narrow claim construction and non-infringement summary judgment. AT&T (No.
As we have previously reported, in November 2023 Regeneron Pharmaceuticals, Inc. District Court for the Northern District of West Virginia, alleging patentinfringement under the Biologics Price Competition and Innovation Act (“BPCIA”) based on the Defendants’ submission of aBLAs for their proposed biosimilars of EYLEA (aflibercept).
Nu Tsai Capital, LLC, [2023-1146] (February 17, 2023), the Federal Circuit vacated a preliminary injunction against Lite-Netics patent-related speech, holding that the district court abused its discretion. Patent Nos. 6 for filing the most patent applications on behalf of those companies. In Lite-Netics, LLC v.
In an opinion released July 27, 2023, the Third Circuit affirmed a 2021 Tax Court decision upholding a pharmaceutical company’s immediate deduction of patent defense litigation costs in suits brought under the Hatch-Waxman Act. By: Eversheds Sutherland (US) LLP
High Stakes: Hatch-Waxman Litigation Comes for Cannabis - GW Pharma, now a subsidiary of Jazz Pharmaceuticals, is no stranger to patentlitigation. It previously found itself on the receiving end of a patentinfringement lawsuit after being accused by Canopy Growth of using its patented extraction technology in 2020.
In a unanimous February 1, 2023 Order , a Federal Circuit panel granted Google LLC’s petition for a writ of mandamus directing the U.S. District Court for the Western District of Texas to vacate its order denying transfer of patentinfringement claims to the Northern District of California.
And 2023 was no exception to that rule. Eli Lilly decisions provide a glimpse into what litigants can expect in the aftermath of the GSK v. Court of appeals for the Federal Circuit or the Supreme Court, they can be an important proving ground for the decisions rendered by those courts. As discussed below, the Zogenix v.
2021-1858, 2023 WL 7267010 (Fed. 3, 2023) - The consequences of pushing zealous advocacy beyond reasonable limits can be severe. million attorneys’ fee award to the alleged infringer after over a decade of patentinfringementlitigation. In re PersonalWeb Techs. By: Irwin IP LLP
Highlight of the Week Comments on the Draft Patent (Amendment) Rules, 2023 Image by rawpixel.com on Freepix Comments pertaining to transparency and on substantive proposals within the draft Patent (Amendment) Rules, 2023, submitted to the Ministry of Commerce. What’s the best way forward?
Aparajita wrote on the potential impact of the recently passed Jan Vishwas Bill, 2023. Read on for his take on what this means for future trademark litigations. Aditya is an attorney at Ira Law and represents Google in trademark litigation relating to keyword advertising. DRS Logistics. Anything important we’re missing out on?
The manufacturer patented the drug but keeps the “data, specifications, and methods for manufacturing the drug confidential.” ” A generic manufacturer sought FDA approval, and the Yondelis manufacturer sued them for patentinfringement. The parties are already in litigation. 2023 WL 7036466 (3d Cir.
A nearly decade-long patentinfringement clash between two pharmaceutical heavyweights reached its apogee on March 27, 2023, when the Supreme Court heard the two parties (and the government) argue an issue that will have wide-reaching impact on technology protections: the Patent Act’s enablement requirement, particularly as applied to functional genus (..)
Not often do such lofty constitutional principles intersect with patentlitigation. 2023-1146 (Fed. 17, 2023), upholds strong free speech rights for patent holders. And if we the People are to govern ourselves, we must have these rights, even if they are misused by a minority.” Nu Tsai Capital, LLC, No.
On June 1, 2021, the Fourth Amendment to the Chinese Patent Law became effective. An important part of the amendment is the introduction by Article 76 of the patent linkage system in China – a system for litigation of drug patents prior to market entry of generics, similar to that provided by the Hatch Waxman Act in the US.
The Federal Circuit’s brief order sheds some light on the standards for amending pleadings late in litigation and the propriety of declaratory judgment counterclaims in patent cases even where the underlying infringement claims have been extinguished. Intel case was before the Federal Circuit in December 2023.
Patentinfringement and remedies 5. SEP litigation Overall, the responses from both SEP holders and implementers reported problems related to the efficiency or effectiveness of the ecosystem around SEPs. Competition and market functioning 3. Transparency in the system 4. Licensing of SEPs 6. Full press release here.]
1:23-cv-294, 2023 WL 6146706 (N.D. 20, 2023) , demonstrates the balancing act between a party’s interest in keeping information confidential and the public’s interest in open court records. These discussions involve both in-suit patents as well as an uninvolved patent. 3d 919, 938-39 (6th Cir.
Do common law doctrines such as the doctrine of (un)clean hands apply in the consideration of a patentee's claim for patentinfringement in South Africa? Patentee not the patent! Bayer had sued Villa Crop for patentinfringement. the patentee) and not the patent. its defence). Paras 64-65].
In October 2023, the International Trade Commission (the “ITC”) ruled that the blood oxygen monitoring features in these devices infringed a patent from Masimo, a medical device company. The answer highlights some of the pros and cons of using the ITC to enforce patents over federal district courts.
Court of Appeals for the Federal Circuit has begun 2023 with its first precedential patent decision in DexCom, Inc. 2023-1795 (Fed. After an extended bit of patentlitigation, the parties entered a 2014 settlement agreement that included a mutual covenant not to challenge each other’s patents again until 2021.
We organize all of the trending information in your field so you don't have to. Join 9,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content